Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 63NETWORK 2NIH 1FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Sleep Wake Disorders 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Exercise Test × Clear all
NCT00819208 2026-04-24

CHALLENGE

Canadian Cancer Trials Group

Phase NA Completed
889 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT06069115 2025-02-11

RELIEF-COHORT

Meshalkin Research Institute of Pathology of Circulation

Recruiting
200 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡